Autism-Spectrum-Disorder: F84.0, F84.1, F84.5 F84.0 F84.1 F84.5
Conditions
Interventions
Group 1: Treatment as usual (TAU)
Group 2: SCOTT&EVA is a software-based training program for the recognition of 40 different emotions from facial expressions, tone of voice, and complex social situat
Sponsors
Klinik für Psaychiatrie und Psychotherapie, Universitätsklinikum Freiburg, Medizinische Fakultät
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (+) ASD (ICD-10: F84.0, F84.5 or F84.1 (provided DSM criterion A, social communication and social interaction, is met) (+) Age between 18 and 65 (+) IQ of at least 80 (+) Relevant psychosocial difficulties (global functioning level (GAF) score = 60) (+) Fluent German language skills of the study participants and parents/partners/other close persons, so that they can complete the questionnaire and understand the instructions (+) Ability of the study participants to understand the nature and individual consequences of the clinical study (+) Signed informed consent (+) Sufficient ability to communicate in groups (+) Reading and writing without significant impairment (+) No or stable psychopharmacological treatment (+) Presence of a person who can complete the informant questionnaire SRS-A (parent/partner/other close person)
Exclusion criteria
Exclusion criteria: (-) Psychiatric comorbid disorders: acute (florid) psychosis, acute (florid) schizophrenia, acute bipolar or other neurological disorder, acute severe depression, acute suicidality (-) Substance abuse / substance dependence within the last 12 months (-) Current or previous gambling addiction (-) Uncorrected severe visual or hearing impairment (-) Severe group-disruptive behavior in the past (-) Any neurological disease or medical condition that is not compatible with group therapy (-) Group-oriented social skills training or other structured psychotherapy targeting the core symptoms of ASD (currently or within the last 6 months before study start; structured psychotherapy for comorbid disorders is allowed) (-) Inpatient clinical stay at T0
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GAF external assessment, change four months after randomization or after the sixteen four-month therapy sessions | — |
Secondary
| Measure | Time frame |
|---|---|
| (1a) Difference in the total score change of the SRS-A, other- and self-assessment (1b) Difference in the change of the external and self-description in the five subscales of the SRS-A (1c) Difference in the change of the modified SRS-A for the total score and the five subscales for both external and self-description (2) General psychiatric well-being [ Depression: BDI-II, social anxiety and deficits in social skills: SASKO] | — |
Countries
Germany
Contacts
Public ContactLudger Tebartz van Elst
Universitätsklinikum Freiburg, Medizinische Fakultät, Klinik für Psychiatrie und Psychotherapie
Outcome results
None listed